跳至主要内容
临床试验/NCT03365622
NCT03365622已完成4 期

Randomized, Double-Blind Clinical Study Evaluating Efficacy of Intravenous Versus Enteric Acetaminophen in Donor Nephrectomy and Robot-Assisted, Laparoscopic Nephrectomy.

University of Rochester1 个研究点 分布在 1 个国家目标入组 214 人开始时间: 2018年8月8日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
214
试验地点
1
主要终点
Total Opioid Dose (MME) Used in 24 Hours

研究概览

简要总结

The aim of this study is to determine whether intravenous acetaminophen compared to enteric acetaminophen offers increased efficacy in patients who are scheduled for laparoscopic donor nephrectomy and for patients scheduled for robot-assisted, laparoscopic nephrectomy for cancer at the University of Rochester Medical Center. The standard surgical and post-operative care, including post-operative pain management will not be altered.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be at least 18 years old
  • Be scheduled for donor nephrectomy or robot-assisted, laparoscopic nephrectomy for cancer at University of Rochester Medical Center
  • Have cognitive ability to verbally rate their pain on the Numeric Rating Scale (NRS).

排除标准

  • Age younger than 18 years old or older than 90 years old
  • Pregnancy (Pre-operative pregnancy test is standard of care for all elective operating room cases)
  • Weight less than 50 kg
  • Epidural use
  • History of known liver disease.
  • Patient unable to take enteral medications.
  • Be taking opioid medications chronically.

研究组 & 干预措施

placebo IV (normal saline) + oral acetaminophen

Placebo Comparator

干预措施: Acetaminophen (Drug)

IV acetaminophen and placebo pills

Active Comparator

干预措施: Acetaminophen (Drug)

IV acetaminophen and placebo pills

Active Comparator

干预措施: Placebo Oral Tablet (Drug)

placebo IV (normal saline) + oral acetaminophen

Placebo Comparator

干预措施: Placebos (Drug)

结局指标

主要结局

Total Opioid Dose (MME) Used in 24 Hours

时间窗: 20 to 24 hours post-operatively

Total opiate dose used from the study start (when the first dose of acetaminophen is administered in the pre-anesthesia holding area) to 24 hours post-operatively (in morphine milligram equivalents (MME)).This will include opiates administered intra-operatively.

次要结局

  • Average Surgical Pain Intensity(1-2 hours post-operatively)
  • Mean Inspiratory Capacity(20-24 hours post-operatively)
  • Dynamic Pain Score During Incentive Spirometer Use(20-24 hours post-operatively)
  • Surgical Pain Score During the 20-24 Hour Assessment(20-24 hours post-operatively)
  • Time to First Narcotic Use(24 hours post-operatively)
  • Number of Participants With Nausea(24 hours post-operatively)
  • Time to Discharge From Post-anesthesia Care Unit(24 hours)
  • Time to Hospital Discharge(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joseph W Dooley, MD

Associate Professor

University of Rochester

研究点 (1)

Loading locations...

相似试验

Efficacy of IV Acetaminophen Versus Oral... | 临床试验